Orquez, Carizaeda .

HRN: 26-13-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/01/2026
03/08/2026
IVTT
280mg
Q6h
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: